clock menu more-arrow no yes

Filed under:

Letter: There is no downside to Utah’s hydroxychloroquine purchase

Letter to the editor Deseret News

Congratulations to Utah lawmakers for having the foresight to purchase more than 20,000 doses of hydroxychloroquine as a treatment for COVID-19. Dr. Deborah Birx said this week that there is an inverse relationship between patients’ age and the severity of COVID-19. The deaths Utah has experienced coincide with this.

It’s important to have a large supply of hydroxychloroquine on hand in the state (as they do in other competent states) to treat people who ask for it. There may never be a vaccine for this disease, so we must use the treatments available to us. There is no vaccine for the common cold, and after 40 years, there is no vaccine for HIV.

Utah can’t go wrong with its supply of hydroxychloroquine. If the virus disappears (unlikely), this supply will always be available for people with lupus and rheumatoid arthritis, or for people who are traveling to malaria-prone countries. It could also be used prophylactically by medical workers, pharmacists and others at risk.

There is no downside.

Sylvia Bennion

Salt Lake City